87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp
Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

by Huntsman Cancer Institute at the University of UtahCredit: Artem Podrez from PexelsA Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Canc

Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

by Huntsman Cancer Institute at the University of UtahCredit: Artem Podrez from PexelsA Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Canc
New theranostic approach effectively detects and treats neuroendocrine prostate cancer

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe
RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc
FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a
Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat
Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe
Molecular test for bile duct cancer nearly doubles detection rate

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de
Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu
New study uncovers mechanism explaining how obesity increases cancer risk

New study uncovers mechanism explaining how obesity increases cancer risk

by Zen Logsdon,City of Hope National Medical CenterCredit: beyzahzah from PexelsScientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining ex

New study uncovers mechanism explaining how obesity increases cancer risk

by Zen Logsdon,City of Hope National Medical CenterCredit: beyzahzah from PexelsScientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining ex
Study finds a U-shaped link between ovarian cancer diagnosis time and survival

Study finds a U-shaped link between ovarian cancer diagnosis time and survival

byUNC Gillings School of Global Public HealthCredit: Elina Fairytale from PexelsOvarian cancer is hard to diagnose early. Its symptoms, like bloating and abdominal pain, are vague and similar to other

Study finds a U-shaped link between ovarian cancer diagnosis time and survival

byUNC Gillings School of Global Public HealthCredit: Elina Fairytale from PexelsOvarian cancer is hard to diagnose early. Its symptoms, like bloating and abdominal pain, are vague and similar to other